Masha Chapman

Masha Chapman has extensive work experience in the field of biotech equity research. Masha started their career at Piper Jaffray as an Associate in Biotech Equity Research from June 2007 to June 2008. Masha then moved on to Cowen and Company, where they worked as an Associate in Biotech Equity Research from June 2008 to June 2010. Masha then joined Bank of America as Vice President - Biotech Equity Research from June 2010 to January 2014. Masha continued their career at JMP Securities LLC as VP, Biotech Equity Research Analyst from January 2014 to February 2016. Masha then worked at Capital Group | American Funds as a Healthcare Equity Research Specialist from February 2016 to May 2021. Currently, they hold a role in Corporate and Business Development at Neurogene Inc. starting from May 2021.

Masha Chapman has a Bachelor of Science (BS) degree in Mathematics from Kazakh State University.